As shown in Fig. 7A, the treatment with this drug combination efficiently reversed the expression of anti-apoptotic BCL2 protein and pro-apoptotic BIM protein in LOUCY ETP-ALL cell line expressing ZEB2. This evidence concerns the gene BCL2 and acute lymphoblastic leukemia.